ARTICLE | Clinical News
BIND-014: Phase II halted
April 18, 2016 7:00 AM UTC
Bind halted further enrollment in the open-label, international Phase II iNSITE 2 trial evaluating IV BIND-014 after the product led an ORR of 10% in the SCCHN cohort (n=20) and 0% in the cervical can...